REGENTIS BIOMATERIALS
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for tissue regeneration. The companyโs core technology is a iodegradable hydrogel called Gelrinโข. It is based on polyethylene glycol diacrylate and denatured fibrinogen originally developed at the Technion University by Dr. Dror Seliktar. The Gelrin hydrogel platform combines the stability and versatility of a synthetic material with the bio-functionality of a natural substance for a range of clinical applications and has undergone extensive preclinical and safety testing over the last few years. The companyโs flagship product, GelrinCโข,designed for the treatment of articular cartilage lesions, is currently in clinical trials.
REGENTIS BIOMATERIALS
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2004-01-01
Address:
Or Akiva, Hefa, Israel
Country:
Israel
Website Url:
http://www.regentis.co.il
Total Employee:
11+
Status:
Active
Contact:
97248546644
Email Addresses:
[email protected]
Total Funding:
36.08 M USD
Technology used in webpage:
Domain Not Resolving ASP.NET IIS IIS 8 Parallels Plesk Panel Plesk Shockwave Flash Embed Classic ASP IIS 6 Microsoft Office Web Server
Similar Organizations
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
Tandem Diabetes Care
Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Regentis Biomaterials
Medica Venture Partners
Medica Venture Partners investment in Series D - Regentis Biomaterials
T3
T3 investment in Series D - Regentis Biomaterials
Haisco
Haisco investment in Series D - Regentis Biomaterials
SCP Vitalife Partners
SCP Vitalife Partners investment in Series D - Regentis Biomaterials
Generali Investments Europe
Generali Investments Europe investment in Series D - Regentis Biomaterials
SCP Vitalife Partners
SCP Vitalife Partners investment in Series C - Regentis Biomaterials
Medica Venture Partners
Medica Venture Partners investment in Series C - Regentis Biomaterials
DSM Venturing
DSM Venturing investment in Series C - Regentis Biomaterials
ProSeed Venture Capital Fund
ProSeed Venture Capital Fund investment in Series B - Regentis Biomaterials
Official Site Inspections
http://www.regentis.co.il
- Host name: 87.140.167.72.host.secureserver.net
- IP address: 72.167.140.87
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260